Study number 8539-034
Group C2b Screening through 15May. Participants Needed!
Dates
Jun 04 2025-Sep 25 2025
Location
Dallas, Texas
Age
18-65
Gender
Both Males and Females
Smoker
Yes
Compensation
$15,115
Group
Pt B C2b
Study Details
The investigational drug in this research study is being developed for the treatment of vitiligo, a disease that causes loss of skin color in patches, and related autoimmune disorders. This is the first time that this study drug is being given to humans.
Fortrea Dallas, Tx is recruiting for:
-Healthy Men and Women, age 18-65
-Body Mass Index between 18-32
-Study involves 3 separate stays totaling 12 nights & 10 follow-up visits
-Compensation up to $15,115 may be provided for time and participation
-Refer a friend to receive $350 per qualified referral
*Females must be of nonchildbearing potential
Additional Details
Pt B C2b:
Check-in: Jun 4, 18, Jul 2
Check-out: Jun 11, 20, Jul 5
Follow-up: Jun 15, 25, Jul 9, 13, 17, 31, Aug 14, 28, Sep 11, 25